Related Experiment Video
Updated: Oct 8, 2026

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
Toxicological effects of areca nut and tobacco leaf extracts alone and in combination in mice
Xiao-Peng Zhong1, Yi-Yan Ma1, Si-Min Yao1
1School of Life and Health Science, Hunan University of Science and Technology, Xiangtan, China.
Abstract:
This study investigated the toxicological interactions between tobacco leaf and areca nut extracts in mice, focusing on hepatic and systemic metabolic functions. Mice received tobacco extract, areca nut extract, or their combination for 14 days. Serum biochemical markers, hepatic function, lipid metabolism, antioxidant enzyme activities, inflammatory mediators, and liver histopathology were evaluated. Tobacco extract induced hepatocellular injury, Cyclooxygenase-2 (COX-2)-mediated inflammation, and impaired antioxidant defenses, whereas areca nut extract primarily disrupted hepatic lipid metabolism. Combined exposure partially alleviated tobacco-induced toxicity, with aspartate aminotransferase (AST), direct bilirubin (DBIL), and blood urea nitrogen (BUN) approaching control levels, reduced hepatic lipid vacuolization through modulation of fatty acid synthase (FASN) and 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), and attenuated inflammatory infiltration. Semi-quantitative histopathological scoring confirmed significantly lower liver injury in the combined exposure group than in the tobacco group. However, antioxidant capacity remained impaired, as indicated by decreased SOD, CAT, and GSH-Px activities and elevated MDA levels, suggesting persistent oxidative stress. These findings demonstrate distinct yet interactive toxicological effects of tobacco and areca nut extracts, providing new mechanistic insights into their combined biological impacts and informing future toxicological studies.
Related Concept Videos
Toxicity Testing in Animals
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...

